POS5 THE COST-EFFECTIVENESS OF IBANDRONATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS IN THE US
May 1, 2006, 00:00
10.1016/S1098-3015(10)64807-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)64807-3/fulltext
Title :
POS5 THE COST-EFFECTIVENESS OF IBANDRONATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS IN THE US
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64807-3&doi=10.1016/S1098-3015(10)64807-3
First page :
Section Title :
Open access? :
No
Section Order :
228